Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the acquisition of Consolidated Graphics, Inc. on behalf of its shareholders. R. R. Donnelley & Sons Company (RRD) and Consolidated Graphics, Inc. (CGX) jointly announced today that they have signed a definitive agreement by which RR Donnelley will acquire Consolidated Graphics.
Under the terms of the transaction, Consolidated Graphics shareholders will receive a combination of $34.44 in cash and a fixed exchange ratio of 1.651 RR Donnelley shares for each outstanding share of Consolidated Graphics they own or $62 per share based on RR Donnelley's closing share price on October 23rd. This consideration represents a transaction value of approximately $620 million, plus the assumption of Consolidated Graphics' net debt.
The investigation concerns whether the senior management and board of directors of CGX breached their fiduciary duties to shareholders by not engaging in a full and fair process to insure that its shareholders received the maximum value for their shares. Indeed., the merger offer is BELOW what CGX was trading at the day prior to when the deal was announced ($63.60) and is below what analysts have projected the true inherent value of the stock is ($65).
If you are a CGX shareholder and would like additional information as to how this acquisition affects your rights as a shareholder, please contact us at no cost to 1-877-772-3975 or email at contact @ tripplevy
Tripp Levy PLLC is a national law firm with extensive experience in mergers and takeovers and has recovered millions for shareholders around the globe. Attorney Adversting. Prior results do not indicate similar outcome.
In case anyone is interested, I learned that a lawsuit is being filed on behalf of shareholders to recover losses
NEW YORK--(BUSINESS WIRE)--
A lawsuit is being filed against the Board of Directors of Amarin Corporation plc (“Amarin” or the “Company”) (AMRN) for possible violations of federal securities laws.
On October 11, 2013, Amarin shares fell more than 20% to close at $5.09 after the Food & Drug Administration released its briefing documents for the October 16, 2013 advisory committee review of Amarin’s application to expand the use of its drug Vascepa. The FDA briefing documents raised questions about the mineral oil placebo potentially negatively impacting the control group data and consequentially overstating Vascepa’s effectiveness.
If you own Amarin stock and wish to obtain additional information about the lawsuit and your legal rights, please contact 1-877-772-3975
I learned that a lawsuit was filed on behalf of shareholders of ACTV who feel the offer to buyout their shares by Vista for only $14.50 per share is too low. The lawsuit was filed in State Court in California in San Diego County. If you would like more information regarding this lawsuit and how it affects your rights as a shareholder, here is number of law firm to contact: 1-877-772-3975
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it has been retained to represent shareholder of Yongye International. It was announced that the Chairman and CEO of the company is acquiring the remaining shares of Yongye that they do not already own for only $6.69 per share.
The lawsuit being brought on behalf of all shareholders of Yongye concerns whether the board, Chairman and CEO breached their fiduciary duties to shareholders by engaging in their own self interests to buy the company for themselves through an unfair price and process.
If you are a shareholder of Yongye and would like additional information regarding this matter and how it affects your rights as a shareholder at no cost or expense please contact us at 1-877-772-3975 or email at contact @ tripplevy